ERITROPOYETINA RECOMBINANTE PDF

Many translated example sentences containing “eritropoyetina recombinante” – English-Spanish dictionary and search engine for English translations. La farmacocinética de la eritropoyetina recombinante humana en pacientes con nefropatía endémica de los Balcanes. The Pharmacokinetics of Recombinant. Efecto del tratamiento con eritropoyetina recombinante humana sobre la necesidad de transfusión sanguínea en los pacientes críticos. Effect of human.

Author: Kajijora Vicage
Country: Panama
Language: English (Spanish)
Genre: Literature
Published (Last): 16 September 2017
Pages: 497
PDF File Size: 14.80 Mb
ePub File Size: 12.56 Mb
ISBN: 788-3-55134-355-6
Downloads: 79722
Price: Free* [*Free Regsitration Required]
Uploader: Vigrel

El nivel de EPO en plasma previo a la dosis se sustrajo de todos los niveles que se obtuvieron tras administrarla. Erythropoietin resistance and survival in non-dialysis patients with stage chronic kidney disease and heart disease.

The enigma of the metabolic fate of circulating erythropoietin Epo in view of the pharmacokinetics of the recombinant drugs rhEpo and NESP.

Are you a health professional able to prescribe or dispense drugs? Der Mechanismus der Anaemie bie der endemische Nephropathie. Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein NESP.

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years. July Pages The values of C max and t max are comparable to those found by other authors, taking into account the above mentioned differences in methodology. Are you a health professional able to prescribe or dispense drugs?

recomvinante

Eritropoyetina Humana Recombinante Delta –

Introduction Anemia was described as a characteristic of Balkan endemic nephropathy BEN in early reports on the disease, 1,2 so Danilovic 3 included it among the criteria for diagnosis.

All patients were treated thrice weekly recombinwnte h bystandard bicarbonate hemodialysis using polysulphone membrane dialyzers. All analyses were performed using the SPSS ver.

  MANFAAT KAPULAGA PDF

The Journal publishes articles on basic or clinical research relating to nephrology, arterial hypertension, dialysis and kidney transplants. Universidad de Santiago de Compostela. C reactive protein; Epo: Available for Android and iOS devices. Pavlovic-Kentera V, Eritropoyeyina Lj. The group with other kidney diseases consisted of 8 patients with glomerulonephritis, 3 with hypertensive nephropathy, 2 with reflux nephropathy and 1 with polycystic kidney disease.

Continuing navigation will be considered as acceptance of this use.

Br J Clin Pharmacol ; Si continua navegando, consideramos que acepta su uso. Higher dose of erythropoietin for anemia correction in Balkan endemic nephropathy patients. Endemic nephropathy in Yugoslavia. Anemia was described as a characteristic of Balkan endemic nephropathy BEN in early reports on the disease, 1,2 so Danilovic 3 included it among the criteria for diagnosis. Population pharmacokinetics and pharmacodynamics of peptidic erythropoiesis receptor agonist ERA in healthy volunteers.

The authors declare that they have no conflicts of interest related to the contents of this article. SRJ is a prestige metric based on the idea that not all citations are the same. Pharmacokinetics For pharmacokinetic analysis the predose plasma level of Epo was subtracted from all postdose levels of Epo for each patient.

The Impact Factor measures the average number of citations received in a particular year eritropoyeyina papers published in the journal during the two eritropoytina years.

It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. Effect of human recombinant erythropoietin treatment on the need for blood transfusion in critically-ill patients. Show more Show less.

Eritropoyetina Humana Recombinante Delta

Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients. Are you a health professional able to prescribe or dispense drugs? Kidney Int Suppl ; Res Commun Mol Pathol Pharmacol ; Methods Study design and patients The prospective clinical study was performed according rrecombinante good clinical practice and in accordance with the Declaration of Helsinki in three clinical centers. The dose of beta-Epo was adjusted to attain the hemoglobin target range defined by European best practice guidelines for the management of anemia in patients with chronic renal failure You can change the settings or obtain more information by clicking here.

  75173 DATASHEET PDF

Erythropoietin Epo concentration was determined in all samples on the same day by chemiluminescent immunoassay for erythropoietin on an Immulite analyzer Siemens Healthcare Diagnostics. Impact of elevated C-reactive protein levels on erythropoiesis stimulating agent ESA dose and responsiveness in hemodialysis patients. We comply with the HONcode standard for trustworthy health information – verify here. Their main characteristics are presented in Table 1.

The relevant pharmacokinetic parameters were calculated after noncompartmental pharmacokinetic analysis using Kinetica software Thermo Scientific, ver. Subscriber If you already have your login data, please click here. Subscribe to our Newsletter. J Am Soc Nephrol ; However, for revombinante and peptide drugs, dependency on active tissue uptake, binding to intra- and extravascular proteins can substantially increase the value of Vd.